Tubeless Insulin Pump Market Players:
- Insulet Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Roche Diabetes Care
- Cellenovo
- Abbott
- Tandem Diabetes Care
- Valeritas, Inc
- Medtrum Technologies
The tubeless insulin pump market is competitive and new players are emerging. Several global and regional players are competing in this sector. The sector is very innovation driven as the focus is to improve the convenience of end-users. The key players are focused on innovation, partnerships, mergers & acquisitions to increase their tubeless insulin pump market share.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of tubeless insulin pump is estimated at USD 2.86 billion.
The global tubeless insulin pump market size was more than USD 2.4 billion in 2025 and is anticipated to witness a CAGR of more than 21.4%, crossing USD 16.69 billion revenue by 2035.
The North America tubeless insulin pump market will secure over 45% share by 2035, driven by product innovations and rising awareness of advanced diabetic care.
Key players in the market include Insulet Corporation, Tandem Diabetes Care, Roche Diabetes Care, Cellenovo, Abbott, Terumo Corporation.
